Evidence map›Paper›PMID 33082851›Full record

ReviewEcancermedicalscience2020

The care of older cancer patients in the United Kingdom.

Fabio Gomes, Anna Lewis, Rob Morris, Ruth Parks, Tania Kalsi, Gordana Babic-Illamn, Mark Baxter, Kirsty Colquhoun, Lisa Rodgers, Eleanor Smith and 26 more

Abstract readReview
In one paragraph

Review in Ecancermedicalscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Challenges in Geriatric Oncology-A Surgeon's Perspective.Current oncology (Toronto, Ont.) · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Fabio GomesThe Christie NHS Foundation Trust, Manchester M20 4BX, UK.
Anna LewisNottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.
Rob MorrisNottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.
Ruth ParksSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
Tania KalsiGuy's and St. Thomas' NHS Foundation Trust, London SE1 9RS, UK.
Gordana Babic-IllamnGuy's and St. Thomas' NHS Foundation Trust, London SE1 9RS, UK.
Mark BaxterNinewells Hospital, NHS Tayside, Dundee DD2 1SG, UK.
Kirsty ColquhounBeatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow G12 0YN, UK.
Lisa RodgersBeatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow G12 0YN, UK.
Eleanor SmithThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
Alastair GreystokeThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
Neil BaymanThe Christie NHS Foundation Trust, Manchester M20 4BX, UK.
Anthea CreeThe Christie NHS Foundation Trust, Manchester M20 4BX, UK.
Cassandra NgWythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.
Nicola de Liguori CarinoRoyal Manchester Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Simone BasileRoyal Manchester Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
John MooreRoyal Manchester Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Zoe MerchantGreater Manchester Cancer, Manchester M20 4BX, UK.
Daniel SwinsonLeeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK.
Anita ParbhooSouth West Wales Cancer Centre, Swansea Bay University Health Board, Swansea SA2 8QA, UK.
Rachel JonesSouth West Wales Cancer Centre, Swansea Bay University Health Board, Swansea SA2 8QA, UK.
Eleri DaviesUniversity Hospital of Llandough, Cardiff and Vale University Health Board, Cardiff CF64 2XX, UK.
Sarah J DansonDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
Robin YoungDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
Jenna MorganDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
Lynda WyldDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.
Pippa G CorrieCambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Gary J DohertyCambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Kyle CrawfordBelfast Health and Social Care Trust, Belfast BT13 1FD, UK.
Juliet WrightBrighton and Sussex Medical School, University of Brighton, Brighton BN1 9PX, UK.
Malcolm ReedBrighton and Sussex Medical School, University of Brighton, Brighton BN1 9PX, UK.
Fiammetta UgoliniSussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Sussex BN2 5BD, UK.
Michael LindQueen's Centre for Oncology and Haematology, Hull University Teaching Hospitals NHS Trust, Hull HU16 5JQ, UK.
Kwok-Leung CheungSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
Danielle HarariGuy's and St. Thomas' NHS Foundation Trust, London SE1 9RS, UK.
Richard SimcockSussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Sussex BN2 5BD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ageing population poses new challenges globally. Cancer care for older patients is one of these challenges, and it has a significant impact on societies. In the United Kingdom (UK), as the number of older cancer patients increases, the management of this group has become part of daily practice for most oncology teams in every geographical area. Older cancer patients are at a higher risk of both under- and over-treatment. Therefore, the assessment of a patient's biological age and effective organ functional reserve becomes paramount. This may then guide treatment decisions by better estimating a prognosis and the risk-to-benefit ratio of a given therapy to anticipate and mitigate against potential toxicities/difficulties. Moreover, older cancer patients are often affected by geriatric syndromes and other issues that impact their overall health, function and quality of life. Comprehensive geriatric assessments offer an opportunity to identify and address health problems which may then optimise one's fitness and well-being. Whilst it is widely accepted that older cancer patients may benefit from such an approach, resources are often scarce, and access to dedicated services and research remains limited to specific centres across the UK. The aim of this project is to map the current services and projects in the UK to learn from each other and shape the future direction of care of older patients with cancer.

Indexed as

cancergeriatric oncologyolder patientsUnited Kingdom

Identifiers

PMID33082851
PMCPMC7532033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.